You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations.
Click “OK” to confirm you are a Healthcare Professional.
SYMPLICITY™ BLOOD PRESSURE PROCEDURE
The Symplicity blood pressure procedure is a single, minimally invasive procedure that is proven to be safe and effective in helping to lower blood pressure.1–3
Adverse events include, but are not limited to, bruising and pain. Results may vary.
In a three-year study of people taking their prescribed blood pressure medications, the procedure helped reduce blood pressure by 16.7 mmHg.3
More than 25,000 people worldwide have received this procedure.4
Ferruccio, Kasim, and Joseph talk about how the Symplicity blood pressure procedure made a difference in their lives.
These are individual experiences. Their thoughts and opinions are their own. Not everyone will experience the same results.
Symplicity Patient Montage Video - (05:08)
Watch this video to see a montage of patients discussing their experiences with uncontrolled high blood pressure and the Symplicity blood pressure procedure.
More information (see more)
Less information (see less)
Dr. Andrew Sharp explains how the Symplicity blood pressure procedure has helped his patients reduce their blood pressure.
Kandzari et al. Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications. Journal of the American College of Cardiology. 2023;82(19):1809–1823.
Böhm M, Kario K, Kandzari DE, et al. Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial. Lancet. May 2, 2020;395(10234):1444–1451.
Mahfoud F, et al. Outcomes following radiofrequency renal denervation according to antihypertensive medications: subgroup analysis of Global SYMPLICITY Registry DEFINE. Presented at euroPCR 2023. Includes Syplicity Spyral™ and Flex catheters.
Medtronic data on file. Includes Symplicity Spyral™ and Flex catheters.